Celcuity, Inc. (CELC)
110.05
-0.72
(-0.65%)
USD |
NASDAQ |
Jan 23, 16:00
110.06
+0.01
(+0.01%)
After-Hours: 20:00
Celcuity Research and Development Expense (TTM): 140.84M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 585.26M |
| Cidara Therapeutics, Inc. | 131.82M |
| Cogent Biosciences, Inc. | 251.67M |
| Olema Pharmaceuticals, Inc. | 146.78M |
| GRAIL, Inc. | 192.80M |